StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb (BMY) Deal for Celgene (CELG) Will Likely Go Through - Barclays
March 22, 2019 9:33 AM
Barclays analyst Geoff Meacham sees Bristol-Myers Squibb (NYSE: BMY) acquisition of Celgene (NASDAQ: CELG) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Mergers and Acquisitions
Next Articles
Bristol-Myers Squibb (BMY) Board Provides Open Letter Shareholder Regarding Merger Agreement with Celgene Corp. (CELG)
March 25, 2019 7:02 AM
Bristol-Myers Squibb (BMY) PT Raised At BMO On Combination With Celgene
March 20, 2019 6:51 AM